Natixis Catalyst Pharmaceuticals, Inc. Transaction History

Natixis

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $1.27 Million - $1.63 Million	108,300 New	108,300 $1.27 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $1.4 Million - $1.93 Million	-225,377 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $56,514 - $88,443	-10,643 Reduced 4.51%	225,377 $1.87 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $1.23 Million - $1.76 Million	236,020 New	236,020 $1.6 Million

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.